Rizvi Syed Ali-aamir
- SEC CIK
- 0001897621
No open-market purchases or sales filed in the past year.
Current role at each company
- RCKT Rocket Pharmaceuticals, Inc.Chief Medical Officeras of Feb 13, 2026
- PSTX Poseida Therapeutics, Inc.Chief Medical Officeras of Jan 8, 2025
- CRBU Caribou Biosciences, Inc.Chief Medical Officeras of Feb 23, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rizvi Syed Ali-aamir as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRBU Caribou Biosciences, Inc.
Chief Medical Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 20, 2023 (view filing) | Jan 19 | 1 day | Rizvi Syed Ali-aamirChief Medical Officer | SSale | −5.63K | $6.31 | −$35.5K | −8.7%59.4K after |